Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe B Putnam

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
The Annals of Thoracic Surgery|December 23, 2014
Audit of lymphadenectomy in lung cancer resections using a specimen collection kit and checklistRaymond U Osarogiagbon, Srishti Sareen, Ransome Eke, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2012
Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data setJuan J Fibla, Stephen D Cassivi, Alessandro Brunelli, et al.
Cancer|June 23, 2015
Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trialDamian E Dupuy, Hiran C Fernando, Shauna Hillman, et al.
The Annals of Thoracic Surgery|May 20, 2011
Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous diseaseStephen Deppen, Joe B Putnam, Gabriela Andrade, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 28, 2012
Validation of the lung cancer staging system revisions using a large prospective clinical trial database (ACOSOG Z0030)Juan J Fibla, Stephen D Cassivi, Paul A Decker, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 6, 2004
Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patientsAra A Vaporciyan, Arlene M Correa, David C Rice, et al.
Annals of Surgical Oncology|August 18, 2016
Rationale for a Minimum Number of Lymph Nodes Removed with Non-Small Cell Lung Cancer Resection: Correlating the Number of Nodes Removed with Survival in 98,970 PatientsAndres X Samayoa, Todd A Pezzi, Christopher M Pezzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2010
Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trialKatherine M W Pisters, Eric Vallières, John J Crowley, et al.
Oncology (Williston Park, N.Y.)|November 11, 2003
Evaluating the role of serine protease inhibition in the management of tumor micrometastasesJoe B Putnam, David Royston, Ann F Chambers, et al.
Oncology (Williston Park, N.Y.)|October 23, 2003
Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancerJaffer A Ajani, Josephine Faust, James Yao, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
The Annals of Thoracic Surgery|December 23, 2014
Audit of lymphadenectomy in lung cancer resections using a specimen collection kit and checklistRaymond U Osarogiagbon, Srishti Sareen, Ransome Eke, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2012
Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data setJuan J Fibla, Stephen D Cassivi, Alessandro Brunelli, et al.
Cancer|June 23, 2015
Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trialDamian E Dupuy, Hiran C Fernando, Shauna Hillman, et al.
The Annals of Thoracic Surgery|May 20, 2011
Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous diseaseStephen Deppen, Joe B Putnam, Gabriela Andrade, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 28, 2012
Validation of the lung cancer staging system revisions using a large prospective clinical trial database (ACOSOG Z0030)Juan J Fibla, Stephen D Cassivi, Paul A Decker, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 6, 2004
Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patientsAra A Vaporciyan, Arlene M Correa, David C Rice, et al.
Annals of Surgical Oncology|August 18, 2016
Rationale for a Minimum Number of Lymph Nodes Removed with Non-Small Cell Lung Cancer Resection: Correlating the Number of Nodes Removed with Survival in 98,970 PatientsAndres X Samayoa, Todd A Pezzi, Christopher M Pezzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2010
Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trialKatherine M W Pisters, Eric Vallières, John J Crowley, et al.
Oncology (Williston Park, N.Y.)|November 11, 2003
Evaluating the role of serine protease inhibition in the management of tumor micrometastasesJoe B Putnam, David Royston, Ann F Chambers, et al.
Oncology (Williston Park, N.Y.)|October 23, 2003
Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancerJaffer A Ajani, Josephine Faust, James Yao, et al.
Pageof 11